DKNetwork Logo DKNetwork Logo
Austin Reaves Injury Update: 11/5/25 vs. the Spurs

Austin Reaves Injury Update: 11/5/25 vs. the Spurs

Published:

By: Garion Thorne

For the second straight game, Austin Reaves (groin) will be unavailable for the Lakers. Reaves was initially listed as questionable for Wednesday night’s tilt with the Spurs, but the guard has since been ruled out.

It is impossible to overstate how well Reaves has been playing in 2025-26, especially with Los Angeles missing the services of LeBron James (sciatica) to start the season. In fact, Reaves is currently sitting fourth in the NBA in points per game (31.1), tied with Utah’s Lauri Markkanen. The guard also leads the league in free throws made per contest (9.2) and he trails only Luka Doncic on the Lakers’ roster in usage rate at 30.8%. Needless to say, his absence leaves a massive void in Los Angeles’ rotation.

In Monday’s 123-115 win over the Blazers, Dalton Knecht drew the spot start, logging 23.0 minutes and scoring eight points. However, it was sixth man Nick Smith Jr. that really drew the headlines, registering 25 points and dishing out six assists off the bench. Smith’s 29.5% usage rate ranked second on the team. It should be noted that Luka Doncic was inactive for that victory and the NBA’s leader in usage rate will be back in action this evening. However, with just a $4,200 salary on DraftKings, Smith is a clear value option on Wednesday’s late DFS slate.

Garion is a Toronto-based writer who has been playing fantasy sports since elementary school. With a particular affinity for advanced statistics and sabermetrics, he’s been covering DFS Baseball, Football and Basketball for DraftKings dating back to 2018. Prior to that, Garion’s work could be found at FNTSY, SportsGrid, HoopsHype, The New York Daily News and Sportsnet.ca. Still, he is a Dolphins fan, so his decision-making can be questioned from time-to-time.
Disclaimer

All views expressed are my own. I am an employee of DraftKings and am ineligible to play in public DFS or DKSB contests.